Dyax Corp. (NASDAQ:DYAX)
CAPS Rating:
A biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications.
RSS Headlines
Fool UK
Recs
I believe the stock price has reached a floor. Institutions & insiders have started buying in large quantities.
I like betting with insiders who have a stake in the game.